InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Novara Mark David. Officer active across 1 company, notably Tandem Diabetes Care INC. Aggregated, 12 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €12k. Activity tracked since 15 November 2024. The latest transaction was disclosed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Novara Mark David is a declarant linked to Tandem Diabetes Care INC, where he holds the role of EVP & CHIEF COMMERCIAL OFFICER. Across 12 filings in total, the sampled recent filings run from 2024-11-19 to 2026-03-18, with EUR 11741 in buys and EUR 39 in sells, and the modal transaction nature is Option exercise.